Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Dose Escalation Evaluation of the Pharmacokinetic and Hemodynamic Effects of Carperitide in Subjects With Congestive Heart Failure

NCT00259038 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00259038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00259038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Dose Escalation Evaluation of the Pharmacokinetic and Hemodynamic Effects of Carperitide in Subjects With Congestive Heart Failure
Lead sponsor
Daiichi Sankyo
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2004
Completion date
February 28, 2006
Enrollment
162 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

heart decompensation, heart failure, congestive, left ventricular failure, myocardiopathies, systolic or diastolic left ventricular dysfunction